COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

FASTMAS (Fast-Fail Trials in Mood and Anxiety Spectrum Disorders) Kappa Opioid Receptor Phase 1 Study (KOR1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02218775
Recruitment Status : Withdrawn (Funding for the study ended with one subject consented, but not randomized)
First Posted : August 18, 2014
Last Update Posted : May 28, 2015
Yale University
Information provided by (Responsible Party):
Andrew Krystal, Duke University